GBA1 and Parkinson disease: The penetrance of GBA1 increases with age, with the reported penetrance for GBA1 heterozygous mutations ranging from 10% to 30% at 80 years of age, suggesting that the majority of GBA1 heterozygous mutation carriers will never develop PD [59–61].